Neutrophil-to-Lymphocyte ratio as a prognostic biomarker in extremities undifferentiated pleomorphic sarcoma-Reference-Cited by-同舟云学术

Neutrophil-to-Lymphocyte ratio as a prognostic biomarker in extremities undifferentiated pleomorphic sarcoma

Published:2022-06 Issue: Volume:42 Page:101746
ISSN:0960-7404
Container-title:Surgical Oncology
language:en
Short-container-title:Surgical Oncology

Author:

García-Ortega Dorian Yarih^ORCID,Melendez-Fernandez Ana Paulina,Alvarez-Cano Alethia,Clara-Altamirano Miguel Angel,Caro-Sanchez Claudia,Alamilla-Garcia Gabriela,Luna-Ortiz Kuauhyama

Publisher

Elsevier BV

Subject

Oncology,Surgery

Reference27 articles.

1. The 2020 WHO classification: what's new in soft tissue tumor pathology?;Kallen;Am. J. Surg. Pathol.,2021

2. Changing concepts in the pathological basis of soft tissue and bone sarcoma treatment;Hogendoorn;Eur. J. Cancer,2004

3. Undifferentiated pleomorphic sarcoma: long-term follow-up from a large institution;Chen;Cancer Manag. Res.,2019

4. An approach to pleomorphic sarcomas: can we subclassify, and does it matter?;Goldblum;Mod. Pathol.,2014

5. The evolving classification of soft tissue tumours: an update based on the new WHO classification;Fletcher;Histopathology,2006

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neutrophils in the tumor microenvironment: role in tumor progression and potential targeted therapeutic strategy;Journal of Cancer Metastasis and Treatment;2024-03-25

2. The Combined Use of Inflammation Markers, Modified Glasgow Prognostic Score, and Sarculator Nomogram in Extremity Soft Tissue Sarcoma: A Multicenter Observational Study;Cancers;2024-03-06

3. Impact of anthracycline-based chemotherapy on RB1 gene methylation in peripheral blood leukocytes and biomarkers of oxidative stress and inflammation in sarcoma patients;Clinical and Translational Oncology;2024-02-03

4. Association between neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and survival in undifferentiated pleomorphic sarcoma (NLR, PLR, and overall survival in UPS);Surgical Oncology;2023-08

5. Systemic Inflammatory Indices in Second-Line Soft Tissue Sarcoma Patients: Focus on Lymphocyte/Monocyte Ratio and Trabectedin;Cancers;2023-02-08